Getinge AB : 1/28/2014 1:00:00 PM Year-End Report 2013
January 28, 2014 at 06:45 pm IST
By
Share
Reporting period January - December
Order intake rose 4.0% to SEK 25,395 M (24,416) and grew organically by 4.0%
Net sales increased 4.3% to SEK 25,287 M (24,248), corresponding to organic growth of 4.2%
Profit before tax declined 8.2% to SEK 3,153 M (3,436)
Net profit decreased 9.3% to SEK 2,295 M (2,531)
Earnings per share declined 9.4% to SEK 9.59 (10.58)
EBITA before restructuring decreased 1.7% to SEK 4,766 M (4,849).
Adjusted for exchange-rate effects and the medical device tax introduced in the US, EBITA rose 8.3%
A dividend per share of SEK 4.15 (4.15) is proposed, corresponding to SEK 989 M (989)
Reporting period October - December
Order intake rose 4.2% to SEK 6,931 M (6,648), and grew organically by 5.9%
Net sales declined 0.8% to SEK 7,757 M (7,816), corresponding to organic growth of 1.3%
Profit before tax increased 18.1% to SEK 1,709 M (1,447)
EBITA before restructuring increased 6.1% to SEK 2,062 M (1,943). Adjusted for exchange-rate effects and the medical device tax introduced in the US, EBITA rose 14.0%
The acquisition of Pulsion Medical Systems is expected to be completed in the first quarter of 2014
Order intake
The Group's order intake posted a favorable trend for the quarter and grew organically by 5.9%. Accordingly, for the full-year 2013, order intake increased organically by 4.0%, a figure that compares favorably with other global medical technology companies.
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows:
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications.
Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%).
At the end of 2021, the group had 20 production sites worldwide.
Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).